Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Nov 28, 2022
Date Accepted: Apr 6, 2023

The final, peer-reviewed published version of this preprint can be found here:

Prediction of Multimorbidity in Brazil: Latest Fifth of a Century Population Study

Li X, Huang H, Lu Y, Stafford RS, Lima SMdS, Mota C, Shi X

Prediction of Multimorbidity in Brazil: Latest Fifth of a Century Population Study

JMIR Public Health Surveill 2023;9:e44647

DOI: 10.2196/44647

PMID: 37252771

PMCID: 10265407

Morbidity and Prediction of Multimorbidity in Brazil: A latest fifth of a century population study

  • Xiliang Li; 
  • Hang Huang; 
  • Ying Lu; 
  • Randall S Stafford; 
  • Simone Maria da Silva Lima; 
  • Caroline Mota; 
  • Xin Shi

ABSTRACT

Background:

Multimorbidity is characterized by the co-occurrence of two or more chronic diseases, garnering the attention of the health care sector and health policymakers due to severe adverse effects.

Objective:

This paper uses the latest fifth of a century of national health data in Brazil to analyze the impacts of demographic factors and predict the impact of various risk factors on multimorbidity.

Methods:

Data analysis methods include descriptive analysis, logistic regression, and nomogram prediction. The research illustrates a set of national cross-sectional data with a sample size of 877,032. The study period was from 1998, 2003, and 2008 in the Brazilian National Household Sample Survey (PNAD) and 2013 and 2019 in the Brazilian National Health Survey (PNS).

Results:

Overall, females were 1.7 times more likely to suffer from multimorbidity than males ([OR] 1.72, 95% CI 1.69-1.74). The prevalence of multimorbidity was 1.5 times higher among non-working individuals ([OR] 1.51, 95% CI 1.49-1.53) and significantly increased with age. People over 60 years old were about 20 times more likely to have multiple chronic diseases than those between 18-29 years of age ([OR] 19.6, 95% CI 19.15-20.07). The risk of multimorbidity in illiterate individuals was 1.2 times higher than in literate ones ([OR] 1.26, 95% CI 1.24-1.28). The subjective well-being of seniors with multiple chronic diseases was 15 times higher among people without multimorbidity ([OR] 15.29, 95% CI 14.97-15.63). Adults with multimorbidity were more than 1.5 times likely to be hospitalized([OR] 1.53, 95% CI 1.50-1.56) and 1.9 times likely to need medical care ([OR] 1.94, 95% CI 1.91-1.97). These patterns were similar in five cohorts and remained stable for over 21 years. A nomogram model was used to predict multimorbidity prevalence under the influence of various risk factors. The prediction results were consistent with the impacts of logistic regression, among which age and subject well-being had the highest impact on multimorbidity prevalence.

Conclusions:

Our study shows that multimorbidity prevalence has little variation in the latest fifth of a century but varies widely across social groups. We hope that predicting populations with higher risk factors of multimorbidity prevalence will champion policy-making on multimorbidity prevention and management.


 Citation

Please cite as:

Li X, Huang H, Lu Y, Stafford RS, Lima SMdS, Mota C, Shi X

Prediction of Multimorbidity in Brazil: Latest Fifth of a Century Population Study

JMIR Public Health Surveill 2023;9:e44647

DOI: 10.2196/44647

PMID: 37252771

PMCID: 10265407

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.